CTRI/2015/09/006175招募中未知
Gemcitabine and oxaliplatin vs gemcitabine and capecitabine in patients with unresectable Carcinoma gall bladder with obstructive jaundice post PTBD/stenting (PTBD or ERCP). A randomized controlled study.
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- AIIMS
- 入组人数
- 104
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with biopsy or cytology proven unresectable or metastatic carcinoma gall bladder with obstructive jaundice.
- •2. Limited liver or peritoneal metastases with good performance status (ECOG < 3)
- •Adequate organ and bone marrow function.
- •3. Haemoglobin more than 10 g/dl, absolute neutrophil count more than 1.5Ã?109/L, platelets higher than 100 Ã? 109/L.
- •4. Serum creatinine <1.8 mg/100 mL.
- •5. Serum bilirubin <3 mg/100 mL, liver enzymes (AST and ALT) within 3 times the normal limit (5 times in case of diffuse hepatic involvement).
- •6. Eastern Cooperative Oncology Group performance status of <3.
- •7. Prior adjuvant chemotherapy and/or radiotherapy, if given, should have been completed 6 months before enrollment
排除标准
- •1 Diffuse metastases in the liver or disseminated disease
- •2.Gross ascites
研究者
相似试验
已完成
2 期
Phase II study of gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced biliary tract cancer (JASPAC02)gemcitabine refractory advanced biliary tract cancerJPRN-UMIN000003650Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC)40
Unknown
3 期
Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic CholangiocarcinomaCholangiocarcinomaNCT02548195Shanghai Zhongshan Hospital286
招募中
4 期
choice between paclitaxel or carboplatin in cisplatin ineligible advanced urinary bladder cancerCTRI/2020/02/023402ALL INDIA INSTITUTE OF MEDICAL SCIENCES RISHIKESH
进行中（未招募）
1 期
Gemcitabine and Oxaliplatin in the treatment of locally advanced or metastatic transitional cell carcinoma of the urinary tract in patients with impaired renal function and patients who have progressed on a cisplatin-based regimen - GO-80 protocol in TCC urinary tractocally advanced or metastatic transitional cell carcinoma of the urinary tractEUCTR2005-000192-17-GBBarts & The London NHS Trust28
尚未招募
2 期
Triple drug therapy in advanced gall bladder cancerCTRI/2023/10/058358CI, AIIMS